|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,730.00 KRW | +1.17% |
|
-2.75% | -24.78% |
| 05-14 | SCL Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-23 | SCL Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 39.5M | - | - | - | - | - |
| 67.6B | |||||
| 51.32B | |||||
| 42.97B | |||||
| 40.81B | - | ||||
| 29.12B |
- Stock Market
- Stocks
- A246960 Stock
- Charts SCL Science Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
